Elite Pharmaceuticals, ticker symbol ELTP, is receiving a high rating this evening from me. In full disclosure, I own no shares of the company and have not been paid to promote it.
The company is generating over a million dollars of revenue per quarter, and is wisely investing in R&D to propel future growth. The stock is attractively valued at only .29 per share and I believe that now is a great time to buy shares of it. I firmly believe that this stock could potentially reach $1 per share in price in short order.
The company is generating over a million dollars of revenue per quarter, and is wisely investing in R&D to propel future growth. The stock is attractively valued at only .29 per share and I believe that now is a great time to buy shares of it. I firmly believe that this stock could potentially reach $1 per share in price in short order.
No comments:
Post a Comment